[1] Umeda N, Kamath PS: Hepatopulmonary syndrome and portopulmonary hypertension. Hepatology research:the offcial journal of the Japan Society of Hepatology 2009, 39:1020-1022.

[2] Ho V: Current concepts in the management of hepatopulmonary syndrome. Vascular health and risk management 2008, 4:1035-1041.

[3] Hoeper MM, Krowka MJ, Strassburg CP: Portopulmonary hypertension and hepatopulmonary syndrome.Lancet 2004, 363:1461-8.

[4] Schraufnagel DE, Malik R, Goel V, Ohara N, Chang SW: Lung capillary changes in hepatic cirrhosis in rats.The American journal of physiology 1997, 272:L139-47.

[5] Gomez FP, Martinez-Palli G, Barbera JA, Roca J, Navasa M, Rodriguez-Roisin R: Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology 2004, 40:660-6.

[6] Berthelot P, Walker JG, Sherlock S, Reid L: Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. The New England journal of medicine 1966, 274:291-8.

[7] Stanley NN, Williams AJ, Dewar CA, Blendis LM, Reid L: Hypoxia and hydrothoraces in a case of liver cirrhosis: correlation of physiological, radiographic, scintigraphic, and pathological fndings. Thorax 1977,32:457-71.

[8] Teuber G, Teupe C, Dietrich CF, Caspary WF, Buhl R, Zeuzem S: Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. European journal of internal medicine 2002, 13:311-8.

[9] Babbs C, Warnes TW, Haboubi NY: Non-cirrhotic portal hypertension with hypoxaemia. Gut 1988, 29:129-31.

[10] Lee J, Menkis AH, Rosenberg HC: Reversal of pulmonary arteriovenous malformation after diversion of anomalous hepatic drainage. The Annals of thoracic surgery 1998, 65:848-9.

[11] Kinane TB, Westra SJ: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2004. A four-year-old boy with hypoxemia. The New England journal of medicine 2004,351:1667-75.

[12] Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, Bosch J: Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. The American review of respiratory disease 1987,135:1085-92.

[13] Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, Navasa M, Rodes J, Rodriguez-Roisin R:Hepatopulmonary syndrome in candidates for liver transplantation. Journal of hepatology 2001, 34:651-7.

[14] Edell ES, Cortese DA, Krowka MJ, Rehder K: Severe hypoxemia and liver disease. The American review of respiratory disease 1989, 140:1631-5.

[15] Eriksson LS, Soderman C, Ericzon BG, Eleborg L, Wahren J, Hedenstierna G: Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: evidence for a hepatopulmonary syndrome. Hepatology 1990, 12:1350-7.

[16] Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH:Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2)response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest 2000, 118:615-24.

[17] Genovesi MG, Tierney DF, Taplin GV, Eisenberg H: An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Limitation of conventional techniques. The American review of respiratory disease 1976, 114:59-65.

[18] Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS: Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. The American journal of medicine 1991,90:693-700.

[19] Daoud FS, Reeves JT, Schaefer JW: Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. The Journal of clinical investigation 1972, 51:1076-80.

[20] Naeije R, Hallemans R, Mols P, Melot C: Hypoxic pulmonary vasoconstriction in liver cirrhosis. Chest 1981, 80:570-4.

[21] Evans JW, Wagner PD: Limits on VA/Q distributions from analysis of experimental inert gas elimination.Journal of applied physiology: respiratory, environmental and exercise physiology 1977, 42:889-98.

[22] Castaing Y, Manier G: Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients.Chest 1989, 96:1064-9.

[23] Dantzker DR, Bower JS: Pulmonary vascular tone improves VA/Q matching in obliterative pulmonary hypertension. Journal of applied physiology: respiratory, environmental and exercise physiology 1981,51:607-13.

[24] Agusti AG, Roca J, Gea J, Wagner PD, Xaubet A, Rodriguez-Roisin R: Mechanisms of gas-exchange impairment in idiopathic pulmonary fbrosis. The American review of respiratory disease 1991, 143:219-25.

[25] Kato M, Staub NC: Response of small pulmonary arteries to unilobar hypoxia and hypercapnia. Circulation research 1966, 19:426-40.

[26] Hedenstierna G, Soderman C, Eriksson LS, Wahren J: Ventilation-perfusion inequality in patients with nonalcoholic liver cirrhosis. The European respiratory journal 1991, 4:711-717.

[27] Voro'bev LP, Maev IV: [Hepatopulmonary syndrome in diffuse diseases of the liver]. Sovetskaia meditsina 1989:44-8.

[28] Agusti AG, Roca J, Rodriguez-Roisin R, Mastai R, Wagner PD, Bosch J: Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis. The American review of respiratory disease 1989, 139:485-91.

[29] West JB: Effects of ventilation-perfusion inequality on over-all gas exchange studied in computer models of the lung. The Journal of physiology 1969, 202:116.

[30] Dantzker DR: The infuence of cardiovascular function on gas exchange. Clinics in chest medicine 1983,4:149-159.

[31] Martini GA, Baltzer G, Arndt H: Some aspects of circulatory disturbances in cirrhosis of the liver. Progress in liver diseases 1972, 4:231-250.

[32] Rodriguez-Roisin R, Wagner PD: Clinical relevance of ventilation-perfusion inequality determined by inert gas elimination. The European respiratory journal 1990, 3:469-482.

[33] Gomez FP, Barbera JA, Roca J, Burgos F, Gistau C, Rodriguez-Roisin R: Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology 2006, 43:1084-1091.

[34] Philit F, Wiesendanger T, Gille D, Boillot O, Cordier JF: Late resolution of hepatopulmonary syndrome after liver transplantation. Respiration; international review of thoracic diseases 1997, 64:173-175.

[35] Bosch J: Vascular deterioration in cirrhosis: the big picture. Journal of clinical gastroenterology 2007, 41 Suppl 3:S247-S253.

[36] Fallon MB, Abrams GA, McGrath JW, Hou Z, Luo B: Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome. The American journal of physiology 1997,272:G779-G784.

[37] Tieppo J, Vercelino R, Dias AS, Marroni CA, Marroni N: [Common bile duct ligation as a model of hepatopulmonary syndrome and oxidative stress]. Arquivos de gastroenterologia 2005, 42:244-248.

[38] Arias-Stella J, Saldana M: The Terminal Portion Of the Pulmonary Arterial Tree In People Native To High Altitudes. Circulation 1963, 28:915-925.

[39] Houston CS, Sutton JR, Cymerman A, Reeves JT: Operation Everest Ⅱ: man at extreme altitude. Journal of applied physiology 1987, 63:877-882.

[40] Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM,Houston CS: Operation Everest Ⅱ: elevated high-altitude pulmonary resistance unresponsive to oxygen.Journal of applied physiology 1987, 63:521-530.

[41] Rhodes J: Comparative physiology of hypoxic pulmonary hypertension: historical clues from brisket disease.Journal of applied physiology 2005, 98:1092-1100.

[42] Dempsey EC, Das M, Frid MG, Stenmark KR: Unique growth properties of neonatal pulmonary vascular cells: importance of time- and site-specific responses, cell-cell interaction, and synergy. Journal of perinatology: offcial journal of the California Perinatal Association 1996, 16:S2-11.

[43] Reid LM: The Third Grover Conference on the pulmonary Circulation. The control of cellular proliferation in the pulmonary circulation. The American review of respiratory disease 1989, 140:1490-1493.

[44] Stenmark KR, Davie N, Frid M, Gerasimovskaya E, Das M: Role of the adventitia in pulmonary vascular remodeling. Physiology 2006, 21:134-145.

[45] Meyrick B, Reid L: Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. A quantitative ultrastructural study. Laboratory investigation; a journal of technical methods and pathology 1980, 42:603-615.

[46] Thenappan T, Goel A, Marsboom G, Fang YH, Toth PT, Zhang HJ, Kajimoto H, Hong Z, Paul J, Wietholt C, Pogoriler J, Piao L, Rehman J, Archer SL: A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. American journal of respiratory and critical care medicine 2011, 183:1080-1091.

[47] Hislop A, Reid L: New fndings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.British journal of experimental pathology 1976, 57:542-554.

[48] Hislop A, Reid L: Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension. British journal of experimental pathology 1977, 58:653-662.

[49] Meyrick B, Reid L: Pulmonary hypertension. Anatomic and physiologic correlates. Clinics in chest medicine 1983, 4:199-217.

[50] Howell K, Preston RJ, McLoughlin P: Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. The Journal of physiology 2003, 547:133-145.

[51] Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P: Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circulation research 2005, 97:185-191.

[52] Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P, Eddahibi S:Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. American journal of respiratory cell and molecular biology 2000,23:762-771.

[53] Budhiraja R, Hassoun PM: Portopulmonary hypertension: a tale of two circulations. Chest 2003, 123:562-576.

[54] Pellicelli AM, Barbaro G, Puoti C, Guarascio P, Lusi EA, Bellis L, D'Ambrosio C, Villani R, Vennarecci G,Liotta G, Ettore G, Andreoli A: Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation. Angiology 2010, 61:802-806.

[55] Giaid A, Saleh D: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. The New England journal of medicine 1995, 333:214-221.

[56] Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, Hoeffken G: Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001, 120:1562-1569.

[57] Egermayer P, Town GI, Peacock AJ: Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax 1999, 54:161-168.

[58] Maruyama T, Ohsaki K, Shimoda S, Kaji Y, Harada M: Thromboxane-dependent portopulmonary hypertension. The American journal of medicine 2005, 118:93-94.

[59] Zopey R, Susanto I, Barjaktarevic I, Wang T: Transition from hepatopulmonary syndrome to portopulmonary hypertension: a case series of 3 patients. Case reports in pulmonology 2013, 2013:561870.

[60] Ioachimescu OC, Mehta AC, Stoller JK: Hepatopulmonary syndrome following portopulmonary hypertension. The European respiratory journal 2007, 29:1277-1280.

[61] Martinez-Palli G, Barbera JA, Taura P, Cirera I, Visa J, Rodriguez-Roisin R: Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome. Journal of hepatology 1999, 31:1075-1079.

[62] Pham DM, Subramanian R, Parekh S: Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Journal of clinical gastroenterology 2010, 44:e136-140.

[63] Kowalski HJ, Abelmann WH: The cardiac output at rest in Laennec's cirrhosis. The Journal of clinical investigation 1953, 32:1025-1033.

[64] Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J: Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988,8:1151-1157.

[65] Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, Jimenez W, Gaya J, Rivera F, Rodes J:Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988, 94:482-487.

[66] Moller S, Hillingso J, Christensen E, Henriksen JH: Arterial hypoxaemia in cirrhosis: fact or fction? Gut 1998, 42:868-874.

[67] Bernardi M, Di Marco C, Trevisani F, Fornale L, Andreone P, Cursaro C, Baraldini M, Ligabue A, Tame MR, Gasbarrini G: Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 1993, 105:188-193.

[68] De BK, Sen S, Biswas PK, Biswas J, Maity AK: Clinical and haemodynamic aspects of hepatopulmonary syndrome in Indian patients with cirrhosis. Journal of gastroenterology and hepatology 2000, 15:412-416.

[69] Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB: Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998, 114:305-310.